These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2883498)
1. The new genetics: will it pay its way? Chapple JC; Dale R; Evans BG Lancet; 1987 May; 1(8543):1189-92. PubMed ID: 2883498 [TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of antenatal screening for cystic fibrosis. Cuckle HS; Richardson GA; Sheldon TA; Quirke P BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Lieu TA; Watson SE; Washington AE Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468 [TBL] [Abstract][Full Text] [Related]
4. Costs, effects, and savings of screening for cystic fibrosis gene carriers. Wildhagen MF; Hilderink HB; Verzijl JG; Verheij JB; Kooij L; Tijmstra T; ten Kate LP; Habbema JD J Epidemiol Community Health; 1998 Jul; 52(7):459-67. PubMed ID: 9799881 [TBL] [Abstract][Full Text] [Related]
5. The resource implications and service outcomes of genetic services in the context of DNA technology. Beech R; Rona RJ; Mandalia S Health Policy; 1994 Jan; 26(3):171-90. PubMed ID: 10133130 [TBL] [Abstract][Full Text] [Related]
6. Active cascade testing for carriers of cystic fibrosis gene. Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278 [TBL] [Abstract][Full Text] [Related]
7. Direct marketing of cystic fibrosis carrier screening: commercial push or population need? Cuckle H; Lilford R; Wilson J; Sehmi I J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204 [No Abstract] [Full Text] [Related]
8. Implications of the new genetics for screening for cystic fibrosis. Dodge JA Lancet; 1988 Sep; 2(8612):672-4. PubMed ID: 2901527 [No Abstract] [Full Text] [Related]
9. Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia. Tsai MC; Cheng CN; Wang RJ; Chen KT; Kuo MC; Lin SJ J Formos Med Assoc; 2015 Aug; 114(8):722-8. PubMed ID: 23932837 [TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160 [TBL] [Abstract][Full Text] [Related]
12. GIG response to the UK Clinical Genetics Society report "The genetic testing of children". Dalby S J Med Genet; 1995 Jun; 32(6):490-1. PubMed ID: 7666405 [No Abstract] [Full Text] [Related]
13. Effect of the Human Genome Initiative on women's rights and reproductive decisions. Charo RA Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):148-59. PubMed ID: 11653014 [TBL] [Abstract][Full Text] [Related]
14. Antenatal screening for cystic fibrosis: a trial of the couple model. Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277 [TBL] [Abstract][Full Text] [Related]
15. Genetic screening for reproductive planning: methodological and conceptual issues in policy analysis. Asch DA; Hershey JC; Pauly MV; Patton JP; Jedrziewski MK; Mennuti MT Am J Public Health; 1996 May; 86(5):684-90. PubMed ID: 8629720 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of DNA diagnosis for four monogenic diseases. van der Riet AA; van Hout BA; Rutten FF J Med Genet; 1997 Sep; 34(9):741-5. PubMed ID: 9321760 [TBL] [Abstract][Full Text] [Related]